Therefore, we first need to reveal the CCL5/CCR5 distribution in patients’ tissues with respect to glioma stage and glioblastoma subtype, and secondly CCL5 and CCR5 relative expressions in the isolated primary glioblastoma cell lines. Here, CCR5 is linked to glioblastoma.